Vimarsana
Biggest News Aggregation in the World

Epigenetics Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epigenetics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epigenetics Program Today - Breaking & Trending Today

NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer - Vimarsana News

NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer

The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.

Researchers find how pathogenic bacteria trigger Crohn's disease - Vimarsana News

Researchers find how pathogenic bacteria trigger Crohn's disease

The findings of a recent study headed by Weill Cornell Medicine and NewYork-Presbyterian researchers, suggests that changes in a single gene allow dangerous gut bacteria to trigger the inflammation that underlies Crohn's disease.

Find out what triggers Crohn's disease - Vimarsana News

Find out what triggers Crohn's disease

According to a recent study headed by Weill Cornell Medicine and NewYork-Presbyterian researchers, changes in a single gene allow dangerous gut bacteria to trigger the inflammation that underlies Crohn's disease

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn's disease - Vimarsana News

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn's disease

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

New AI blood test technology to detect liver cancer - Vimarsana News

New AI blood test technology to detect liver cancer

A new artificial intelligence blood testing technology developed and used by researchers of Johns Hopkins Kimmel Cancer Center to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.